[1]季晶俊 陈晓宏△ 庞辉群 朱婷 季春燕.强骨胶囊干预老年低骨量患者的临床疗效[J].中国中医骨伤科杂志,2015,23(09):30-32.
　JI Jingjun CHEN Xiaohong PANG Huiqun ZHU Ting JI Chunyan.Clinical Efficacy of Qianggu Capsule in Treatment of Elderly Patients with Low Bone Mass[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2015,23(09):30-32.
点击复制

强骨胶囊干预老年低骨量患者的临床疗效
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第23卷
期数:
2015年09期
页码:
30-32
栏目:
临床研究
出版日期:
2015-09-15

文章信息/Info

Title:
Clinical Efficacy of Qianggu Capsule in Treatment of Elderly Patients with Low Bone Mass
文章编号:
1005-0205(2015)09-0030-03
作者:
季晶俊1 陈晓宏1△ 庞辉群1 朱婷1 季春燕1
1.上海中医药大学附属曙光医院老年医学科(上海,200021)
△.通信作者 E-mail:13311768272@189.cn
Author(s):
JI Jingjun1 CHEN Xiaohong1 PANG Huiqun1 ZHU Ting1 JI Chunyan1
1.Department of Geriatrics,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China.
关键词:
强骨胶囊;  骨质疏松症;  低骨量;  骨密度
Keywords:
qianggu capsule;  osteoporosis;  low bone mass;  bone mineral density
分类号:
R274.39
文献标志码:
A
摘要:
目的:观察强骨胶囊干预老年低骨量患者的临床疗效。方法:79例老年低骨量患者随机分为2组:治疗组40例,对照组39例。治疗组使用强骨胶囊(1粒/次,3次/d),同时予以基础治疗—钙尔奇D(1粒/d)及阿法迪三软胶囊(1粒/d); 对照组予以基础治疗—钙尔奇D(1粒/d)及阿法迪三软胶囊(1粒/d); 疗程均为6个月。结果:1)治疗组在中医症候积分改善方面明显优于对照组(P<0.05)。2)经过治疗治疗组骨密度下降不明显,对照组骨密度下降,两组比较差异有统计学意义(P<0.05)。3)治疗组能增加患者6 min步行距离,明显优于对照组(P<0.05)。4)两组在骨折发生率、骨代谢生化标志物以及不良反应方面无明显差异。结论:强骨胶囊干预治疗可减缓骨量丢失,改善临床症状,提高患者运动能力。
Abstract:
Objective:To observe the clinical efficacy of Qianggucapsule in the treatment of elderly patients with low bone mass. Methods: 79 elderly patients with low bone mass were randomly divided into the treatment group(40 cases)and the control group(39 cases). The treatment group used Qianggu capsule(1s,tid)as well as the basic treatment of Caltrate D(1 grain / day)and α-D3 soft capsules(1 grain/ day); The control group underwent Caltrate D(1 grain / day)andα-D3 soft capsules(1 grain/ day).Both with a course of six months.Results:1)The improvement of Chinese symptom scores in the treatment group is obvious better than that in the control group(P<0.05).2)The bone mineral density in treatment group had no significant decline while the control group decreased, and the difference was statistically significant(P<0.05). 3)The six-minute walk distance in the treatment group increased and it was significantly better than that in the control group(P<0.05).4)There was no significant difference in fracture incidence, biochemical markers of bone metabolism and adverse reactions. Conclusion: Qianggu capsule intervention can reduce bone loss, improve clinical symptoms and increase exercise capacity of patients.

参考文献/References:

[1] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17.
[2] 国家药品食品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:356-358.
[3] 谢雁鸣,许勇钢,赵晋宁,等.骨碎补总黄酮对去卵巢大鼠骨密度和细胞因子IL-6、IL-4、TNFα水平的影响[J].中国中医基础医学杂志,2004,10(1):34-37.
[4] 李杰,黄健华,霍维玲,等.骨碎补总黄酮对人工关节磨损微粒引起单核细胞分泌肿瘤坏死因子-α的影响[J].徐州医学院学报,2013,33(7):529-532.
[5] 陈元良,张寿,钟海波.骨碎补总黄酮对骨性关节炎血清IL-1、IL-8及TNF-α表达的影响[J].陕西中医,2013,34(9):149-150.
[6] 段冠清,蔡莹,沈慧,等. 骨碎补总黄酮含药血清对大鼠成骨细胞AR mRNA表达的影响[J].中医药导报,2010,16(2):61-64.
[7] 李晋玉,徐林,谭荣伟,等.不同浓度骨碎补总黄酮复合可注射骨修复材料对MC3T3-E1成骨细胞作用的实验研究[J].生物骨科材料与临床研究,2014,11(2):53-57.
[8] 李晋玉,金合,俞兴,等.可注射骨修复材料结合骨碎补总黄酮修复大鼠颅骨缺损[J].中国组织工程研究,2013,17(8):1349-1353.
[9] 朱慧锋,程金海,王珠美,等.去卵巢大鼠干预后骨生物力学研究[J].中医正骨,2009,21(8):5-7.
[10] 朱晓兵.强骨胶囊治疗骨质疏松性骨折的临床观察[J].海峡药学,2011,23(5):196-197.
[11] 杨国志,李振武,尹锐峰,等.强骨胶囊联合鲑鱼降钙素针剂辅助治疗老年骨质疏松性压缩骨折临床观察[J].中国骨质疏松杂志,2014,20(2):196-199.

备注/Memo

备注/Memo:
收稿日期:2014-11-07
更新日期/Last Update: 2015-09-15